Drugs for Neglected Diseases Initiative
The Drugs for Neglected Diseases initiative is a collaborative, patients' needs-driven, non-profit drug research and development organization that is developing new treatments for neglected diseases, notably leishmaniasis, sleeping sickness, Chagas disease, malaria, filarial diseases, mycetoma, paediatric HIV, cryptococcal meningitis, hepatitis C, and dengue. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Drugs for Neglected Diseases Initiative, Switzerland, covering academic research published from 2003 to 2024. Read More.
Open Access Percentage
83%
Total
Publications
762
Total Open
Publications
629
Total
Citations
36K
Open Access
Percentage
83%
Total
Publications
762
Total Open
Publications
629
Total
Citations
36K
Breakdown
Publisher Open
12%
Both
61%
Other Platform Open
9%
Closed
18%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 65%
346
Hybrid 22%
117
No Guarantees 13%
66
Other Platform Open
Domain 78%
401
Institution 28%
146
Other Internet 21%
108
Public 9%
47
Preprint 6%
29
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 394 |
DOI | Other Internet | 107 |
Figshare | Public | 48 |
Europe PMC | Domain | 41 |
Royal Netherlands Academy of Arts and Sciences | Institution | 31 |
Le Centre pour la Communication Scientifique Directe - HAL - Diderot | Institution | 28 |
medRxiv | Preprint | 16 |
University College of Arts Crafts and Design | Institution | 13 |
University of Oxford | Institution | 11 |
Médecins Sans Frontières | Institution | 11 |